T-lymphocyte proliferative leukemia can be divided into acute and chronic types, and general treatment, chemotherapy, etc. can be chosen according to the cause of the disease. The details are as follows:
1. Acute lymphoblastic leukemia: if severe anemia occurs, oxygen can be inhaled, concentrated red blood cells can be transfused, timely nutrition can be supplemented, and protein-rich and easy-to-digest food can be given. The etiological treatment is mainly combined chemotherapy and allogeneic hematopoietic stem cell transplantation, and the chemotherapy regimen often used at present is vincristine + levodendrosteridase + prednisone + Zoerythromycin.
2. Chronic lymphocytic leukemia: mostly palliative treatment, the main purpose is to reduce tumor load and improve symptoms. Chemotherapy can use cyclophosphamide, fludarabine and so on. Rituximab can be used for immunotherapy, and ibrutinib can be used for molecular targeted therapy.
If patients are diagnosed with leukemia, they should go to the hospital in time, do not self-medicate to avoid delays or adverse reactions, and follow the doctor’s instructions for treatment.